Stocks To Watch Today: Maruti Suzuki, ITC, STL, Powerica, NCC, Coal India, Divi’s Labs Among Key Shares
Last Updated: 3rd August 2026 - 12:36 pm
Summary:
Several companies are expected to remain in focus on Monday after announcing business developments, regulatory updates, order wins and bulk deals that could influence trading activity.
Join 5paisa and stay updated with Market News
A number of stocks are likely to attract investor attention on August 3 following fresh corporate announcements, project wins, regulatory actions and bulk market transactions. Companies across sectors, including telecom, infrastructure, pharmaceuticals, power and media, disclosed material developments over the weekend that may keep their share price in focus during the trading session.
The updates include new contracts, U.S. FDA approvals, board-level appointments, renewable energy projects and regulatory orders, alongside several notable bulk deals.
Companies Announce Orders And Business Developments
Sterlite Technologies share price may remain in focus after the company secured a multi-year agreement worth ₹960 crore to supply optical fibre cables to a domestic telecom operator.
Powerica share price could also be watched after the company signed a Power Purchase Agreement with Gujarat Urja Vikas Nigam Ltd. to develop a 100 MW wind power project in Gujarat. The project will supply electricity at a tariff of ₹3.435 per kWh for a period of 25 years.
NCC share price is expected to remain active after the company received three orders worth ₹1,052.71 crore during July. Of the total, ₹590.38 crore relates to the buildings division, while ₹462.33 crore has been awarded to its water division.
Bharat Electronics share price will also be tracked after the defence PSU secured additional orders valued at ₹847 crore since July 13 for products and services, including electro-optics, seekers, security systems, spares and related equipment.
Pharma Stocks In Focus On U.S. FDA Approvals
Dr Reddy’s Laboratories share price is likely to be watched after the U.S. Food and Drug Administration approved Rituximab, a biosimilar version of Rituxan, for the U.S. market. The medicine is used in the treatment of certain blood cancers and autoimmune disorders.
Lupin share price may also remain in focus after receiving U.S. FDA approval for Diazepam Injection USP in prefilled single-dose syringes. The product has been approved as a bioequivalent version of Valium Injection.
Meanwhile, Zydus Lifesciences share price could see attention after the company received an Establishment Inspection Report from the U.S. FDA for its injectable manufacturing facility in Ahmedabad with a Voluntary Action Indicated classification following a GMP inspection conducted between April 27 and May 5.
Real Estate, Infrastructure And Corporate Updates
Marathon Nextgen Realty share price will remain on investors’ radar after its subsidiary entered into a joint development agreement for a redevelopment project in Mumbai’s Sewri area. The project has an estimated gross development value of around ₹450 crore for the company.
Afcons Infrastructure share price may also be monitored after the company announced project wins worth nearly ₹900 crore during July.
Container Corporation of India share price could be in focus after Ajit Kumar Panda assumed charge as Chairman and Managing Director with effect from August 1.
Zee Entertainment, Bulk Deals And Other Developments
Zee Entertainment Enterprises share price is expected to remain under watch after the Securities and Exchange Board of India barred the company from the securities market for two months in connection with the Hyderabad property mortgage case. The regulator also restrained Managing Director Punit Goenka and Essel Group founder Subhash Chandra from the securities market for 12 months and imposed a combined penalty of ₹1.48 crore. The company has stated that the order will not affect its ongoing ₹2,300-crore fundraising exercise and is evaluating legal options.
Among bulk deals, Kotak Mahindra Mutual Fund acquired 18.47 lakh shares in Rossell Techsys share price at ₹900 per share, while promoter entities reduced their holdings through corresponding transactions. SageOne Investments increased its stake in Belding India share price, and Carnelian India Multi Strategy Fund exited its holding in Gaudium IVF and Women Health through a bulk sale.
Apart from these developments, investors are also expected to track Maruti Suzuki share price, ITC share price, Coal India share price, Eicher Motors share price, Hero MotoCorp share price, Concord Biotech share price, Glenmark Pharmaceuticals share price, NALCO share price and Divi’s Laboratories share price for stock-specific activity during Monday’s session.
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.
5paisa Capital Ltd